comparemela.com

Shandong Boan Biotechnology Co Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bevacizumab Biosimilar Demonstrates Positive Phase 3 Results for the Treatment of Non-Small Cell Lung Cancer | Goodwin

A study recently published in Cancer Communications reported that LY01008 or BOYOUNUO, a bevacizumab biosimilar developed by Shandong Boan Biotechnology Co., Ltd. (“Shandong Boan”), a.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.